在结构基础的疫苗设计中
Sakshi Piplani1, David Winkler2,3,4, Yoshikazu Honda-Okubo1
1Vaxine Pty Ltd, Adelaide, SA, Australia.
Methods in molecular biology (Clifton, N.J.)
|May 31, 2023
概括
基于结构的疫苗设计 (SBVD) 通过使用蛋白质结构来创建新的疫苗候选人来推进计算疫苗开发. 这种方法由COVID-19疫苗设计突出显示,为未来的疫苗发现提供了新的目标和机会.
科学领域:
- 计算生物学是一种计算生物学.
- 疫苗学 疫苗学 疫苗学
- 结构生物学是结构生物学.
背景情况:
- 基于结构的疫苗设计 (SBVD) 利用详细的蛋白质结构信息来开发新型候选疫苗.
- 蛋白质和抗体结构建模方面的进步打开了新的疫苗目标和发现途径.
- SARS-CoV-2 尖端蛋白质是 SBVD 策略的一个关键例子.
结论:
- 在 silico SBVD 是一种强大的计算方法用于疫苗开发.
- 克服当前的挑战将进一步提高SBVD的能力.
- 在各种疾病中,SBVD对未来的疫苗发现具有重大前景.
相关概念视频
Antibody Structure
60.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.5K
Viral Structure
62.8K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.8K
Structure-Activity Relationships and Drug Design
801
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
801


